Financials

  • Market Capitalization 88.28 M
  • Employee 76
  • Founded 2018
  • CEO N/A
  • Website www.acrivon.com
  • Headquarter Massachusetts, United States
  • FIGI BBG011RWR2Q4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.19
Rapporto prezzo/fatturato
464.04

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3987
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
1.49 USD-3.25%-2.61%-8.59%-74.40%89.89 M USD
3994
RLYB
Rallybio Corporation - Common Stock
16.81 USD+0.30%+1.63%+5.66%+3132.69%89.27 M USD
4003
OKYO
OKYO Pharma Limited - American Depositary Shares
1.67 USD+7.74%+7.74%+2.45%-28.33%87.64 M USD
4011
LNAI
Lunai Bioworks Inc. - Common Stock
2.37 USD+0.85%+9.72%+15.05%+52.90%85.96 M USD

Notizie